ProVerum
Ireland-based developer of the ProVee System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH)
ProVerum has raised €68M across 1 funding round from 7 investors, most recently a Series B round in Aug 2025. Based in Dublin, Ireland; active in Healthtech. Data as of 28 Oct 2026.
Dublin, Irelandwww.proverummedical.com ↗
Total raised
€68M
€68,393,605
Funding rounds
1
Investors
7
distinct backers
Active since
2025-08
latest 2025-08
Funding by year
EUR raised per yearProVerum — funding by year — interactive chart.
Data table
| ProVerum — funding by year | |
|---|---|
| 2025 | €68M |
Signals
High confidenceRaise-next likelihood65
base rate 48% for Series B
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-08-25 | Series B | €68M | Atlantic Bridge,Enterprise Ireland,Gilde Healthcare,Ireland Strategic Investment Fund (ISIF),Lightstone Ventures,MVM Partners+1 more | View deal → |
Investors
7Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Wayflyer€2.1BIreland · E-commerce
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData